SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-21-014175
Filing Date
2021-03-18
Accepted
2021-03-18 16:30:48
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 vtvt-s3.htm S-3 223013
2 EX-5.1 vtvt-ex51_59.htm EX-5.1 12418
3 EX-23.1 vtvt-ex231_6.htm EX-23.1 2623
4 GRAPHIC gkqyr4qroqtx000001.jpg GRAPHIC 14259
5 GRAPHIC gkqyr4qroqtx000002.jpg GRAPHIC 14259
  Complete submission text file 0001564590-21-014175.txt   278702
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254445 | Film No.: 21754747
SIC: 2834 Pharmaceutical Preparations